# ZNF32

## Overview
ZNF32, or zinc finger protein 32, is a gene that encodes a transcription factor involved in various cellular processes, including the regulation of oxidative stress responses and apoptosis. The protein product, zinc finger protein 32, is characterized by its zinc finger domains, which enable it to bind DNA and modulate gene expression. This transcription factor plays a crucial role in maintaining cellular homeostasis by protecting cells from oxidative stress-induced apoptosis through the regulation of complement 1q-binding protein (C1QBP) (Li2015ZNF32a). ZNF32 is implicated in several cancer types, where it influences pathways related to drug resistance and cancer progression, making it a potential target for therapeutic interventions (Li2018Zinc; Li2016ZNF32).

## Function
ZNF32 (zinc finger protein 32) is a transcription factor that plays a significant role in protecting cells from oxidative stress-induced apoptosis. It achieves this by modulating the transcription of complement 1q-binding protein (C1QBP), which is crucial for maintaining mitochondrial membrane potential and reducing reactive oxygen species (ROS) accumulation. This function is vital for cellular homeostasis, as it helps prevent apoptosis under oxidative stress conditions (Li2015ZNF32a).

ZNF32 is regulated by the transcription factor Sp1, which binds to its promoter in response to moderate levels of ROS. This binding enhances ZNF32 transcription, which in turn increases C1QBP expression, supporting mitochondrial function and antioxidant defenses (Li2015ZNF32a). In healthy cells, ZNF32's role in maintaining mitochondrial integrity and supporting the antioxidant system is crucial for cellular resistance to oxidative damage (Li2015ZNF32a).

ZNF32 is active in the nucleus, where it influences gene expression by binding to DNA through its zinc finger domains. This activity impacts various cellular processes, including proliferation, differentiation, and apoptosis, contributing to organismal homeostasis (Li2015ZNF32a).

## Clinical Significance
ZNF32 has been implicated in various cancers due to its role in promoting drug resistance and cancer progression. In breast cancer, overexpression of ZNF32 enhances stem cell-like properties and increases resistance to chemotherapy drugs like Taxol. This is associated with increased expression of stem cell markers and a higher percentage of ALDH1-positive cells, which are indicative of stem/progenitor cells (Li2018Zinc). In lung adenocarcinoma, ZNF32 contributes to multidrug resistance through the TGF-β receptor 2 signaling pathway, leading to poor patient outcomes and increased resistance to treatments such as cisplatin and gefitinib (Li2016ZNF32). 

In hepatocellular carcinoma, ZNF32 is linked to anoikis resistance, a key factor in cancer metastasis, by maintaining redox homeostasis and activating Src/FAK signaling (Li2019ZNF32). In colorectal cancer, ZNF32 promotes self-renewal and tumorigenicity through the LEPR-STAT3 signaling pathway, correlating with poor prognosis and shorter survival in patients (Li2022ZNF32). These findings suggest that ZNF32 expression alterations are significant in cancer progression and treatment resistance, highlighting its potential as a therapeutic target.

## Interactions
ZNF32 interacts with various proteins and nucleic acids, playing a significant role in different cellular processes. In colorectal cancer cells, ZNF32 binds to the promoter region of the leptin receptor (LEPR), enhancing its expression and activating the downstream STAT3 signaling pathway. This interaction promotes the self-renewal capacity of colorectal cancer stem cells (Li2022ZNF32).

In hepatocellular carcinoma, ZNF32 is involved in anoikis resistance by interacting with the Src/FAK signaling pathway. ZNF32 overexpression leads to increased phosphorylation of Src and FAK, enhancing their interaction and promoting cell survival in suspension (Li2019ZNF32).

ZNF32 also plays a role in breast cancer by interacting with the G protein-coupled estrogen receptor (GPER). It binds to the GPER promoter, upregulating its expression and activating the ERK signaling pathway, which contributes to the stem cell-like properties of breast cancer cells (Li2018Zinc).

In lung adenocarcinoma, ZNF32 binds to the TGF-β receptor 2 (TGF-βR2) promoter, increasing its transcription and activating the TGF-β signaling pathway. This interaction is associated with multidrug resistance and poor prognosis in patients (Li2016ZNF32).


## References


[1. (Li2018Zinc) Yanyan Li, Di Gong, Le Zhang, Hongjiang Li, Shu Zhang, Jie Zhang, Kai Li, QianWen Zheng, Gang Zhao, Yue Zhang, Yue Chen, Yafei Guo, Rong Xiang, Ping Lin, and Yuquan Wei. Zinc finger protein 32 promotes breast cancer stem cell-like properties through directly promoting gper transcription. Cell Death &amp; Disease, November 2018. URL: http://dx.doi.org/10.1038/s41419-018-1144-2, doi:10.1038/s41419-018-1144-2. This article has 11 citations.](https://doi.org/10.1038/s41419-018-1144-2)

[2. (Li2015ZNF32a) Kai Li, Bo Gao, Jun Li, Haining Chen, Yanyan Li, Yuyan Wei, Di Gong, Junping Gao, Jie Zhang, Weiwei Tan, Tianfu Wen, Le Zhang, Lugang Huang, Rong Xiang, Ping Lin, and Yuquan Wei. Znf32 protects against oxidative stress-induced apoptosis by modulating c1qbp transcription. Oncotarget, 6(35):38107–38126, October 2015. URL: http://dx.doi.org/10.18632/oncotarget.5646, doi:10.18632/oncotarget.5646. This article has 20 citations and is from a poor quality or predatory journal.](https://doi.org/10.18632/oncotarget.5646)

[3. (Li2016ZNF32) Jun Li, Jie Ao, Kai Li, Jie Zhang, Yanyan Li, Le Zhang, Yuyan Wei, Di Gong, Junping Gao, Weiwei Tan, Lugang Huang, Lunxu Liu, Ping Lin, and Yuquan Wei. Znf32 contributes to the induction of multidrug resistance by regulating tgf-β receptor 2 signaling in lung adenocarcinoma. Cell Death &amp; Disease, 7(10):e2428–e2428, October 2016. URL: http://dx.doi.org/10.1038/cddis.2016.328, doi:10.1038/cddis.2016.328. This article has 13 citations.](https://doi.org/10.1038/cddis.2016.328)

[4. (Li2022ZNF32) Jun Li, Xiaoan Li, Lili Lan, Lin Sun, Xuemei Li, Yaqi Li, Yan Tian, Tongqin Zhang, Yan Zhou, Chunfen Mo, and Xiangsheng Fu. Znf32 promotes the self-renewal of colorectal cancer cells by regulating the lepr-stat3 signaling pathway. Cell Death &amp; Disease, February 2022. URL: http://dx.doi.org/10.1038/s41419-022-04530-4, doi:10.1038/s41419-022-04530-4. This article has 3 citations.](https://doi.org/10.1038/s41419-022-04530-4)

[5. (Li2019ZNF32) Kai Li, Gang Zhao, Jie Ao, Di Gong, Jie Zhang, Yue Chen, Jun Li, Lugang Huang, Rong Xiang, Jiankun Hu, Ping Lin, and Yuquan Wei. Znf32 induces anoikis resistance through maintaining redox homeostasis and activating src/fak signaling in hepatocellular carcinoma. Cancer Letters, 442:271–278, February 2019. URL: http://dx.doi.org/10.1016/j.canlet.2018.09.033, doi:10.1016/j.canlet.2018.09.033. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2018.09.033)